UV-A1 phototherapy improves nephrogenic fibrosing dermopathy.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Archives of Dermatology

• Publication date

  2004-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.140.11.1322PMID 15545539
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nephrogenic fibrosing dermopathy

  2004influential reference
• Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo.

  2003cited by this paper
• Nephrogenic Fibrosing Dermopathy

  2001cited by this paper
• Scleromyxoedema-like cutaneous diseases in renal-dialysis patients.

  2000cited by this paper
• c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid.

  2000cited by this paper
• The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis.

  1998cited by this paper
• A simplified measurement of degraded collagen in tissues: application in healthy, fibrillated and osteoarthritic cartilage.

  1997influential reference

• The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study

  2023cites this paper
• Nephrogenic systemic fibrosis: A frivolous entity

  2021cites this paper
• CCN2 (Cellular Communication Network factor 2) in the bone marrow microenvironment, normal and malignant hematopoiesis

  2021cites this paper
• Photopheresis Provides Significant Long-Lasting Benefit in Nephrogenic Systemic Fibrosis

  2017cites this paper
• Ultraviolet A1 phototherapy: One center's experience

  2017cites this paper
• Phototherapie sklerosierender Hautkrankheiten

  2017cites this paper
• UVA Irradiation Induced Heme Oxygenase‐1: A Novel Phototherapy for Morphea

  2015cites this paper
• Nephrogenic Systemic Fibrosis : Why Should We Be Concerned ? Part 2

  2013cites this paper
• UVA-1 therapy of localized scleroderma and other diseases accompanied by skin sclerosis

  2013cites this paper
• 43 – The Skin and Rheumatic Diseases

  2013cites this paper
• Treatment regimens, protocols, dosage, and indications for UVA1 phototherapy: facts and controversies.

  2013cites this paper
• Renal Transplantation Is Associated with Improved Clinical Outcomes in Nephrogenic Systemic Fibrosis

  2013cites this paper
• Role of UVA 1 phototherapy in treatment of scleroderma and scleroderma-like disorders

  2013cites this paper
• Nephrogenic systemic fibrosis in the podiatric patient.

  2012cites this paper
• Understanding Nephrogenic Systemic Fibrosis

  2012cites this paper
• Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure.

  2012cites this paper
• Cutaneous Manifestations of Renal Disease

  2012cites this paper
• Review papers Role of UVA1 phototherapy in treatment of scleroderma and scleroderma-like disorders”

  2012cites this paper
• Nephrogenic Systemic Fibrosis

  2012cites this paper
• Phototherapy for sclerosing skin conditions.

  2011cites this paper
• Gadolinium-induced nephrogenic systemic fibrosis.

  2011cites this paper
• Nephrogenic systemic fibrosis: a case report and review of the literature.

  2011cites this paper
• Side Effects of Gadolinium Enhanced Magnetic Resonance Imaging in Patients with Renal Failure, a Review.

  2011cites this paper
• A study of the complications associated with haemodialysis vascular access in patients with renal failure

  2010cites this paper
• 13 – Cutaneous mucinoses

  2010cites this paper
• UVA1 phototherapy: a review of mechanism and therapeutic application

  2010cites this paper
• Nephrogenic systemic fibrosis: a review.

  2010cites this paper
• Nephrogenic systemic fibrosis. A debilitating disease causing fibrosis of the skin and inner organs in patients with kidney failure.

  2010cites this paper
• Nephrogenic Systemic Fibrosis: A New Threat in the Use of Gadolinium-Based Contrast Media

  2009cites this paper
• Nephrogenic systemic fibrosis in liver disease: A systematic review

  2009cites this paper
• Estimates of risk, empirical treatment observations, and unexpected laboratory findings reveal the complexity of nephrogenic systemic fibrosis.

  2009cites this paper
• UV-A1 therapy for nephrogenic systemic fibrosis.

  2009cites this paper
• Nephrogenic systemic fibrosis: a review of the new conundrum.

  2009cites this paper
• Nephrogenic systemic fibrosis: Clinical spectrum of disease

  2009cites this paper
• Nephrogenic systemic fibrosis in advanced chronic kidney disease: a single hospital's experience in Taiwan.

  2009cites this paper
• [Nephrogenic systemic fibrosis: a severe complication of use to gadolinium in patients with kidney failure].

  2009cites this paper
• UV-A 1 Therapy for Nephrogenic Systemic Fibrosis

  2009influential citation
• Placa indurada en abdomen

  2009cites this paper
• Fibrose sistêmica nefrogênica: uma complicação grave do uso do gadolínio em pacientes com insuficiência renal

  2009cites this paper
• Dermopatía nefrogénica fibrosante / fibrosis sistémica nefrogénica

  2009cites this paper
• Fibrosis sistémica nefrogénica

  2009cites this paper
• The Skin and Rheumatic Diseases

  2009cites this paper
• Cutaneous manifestations of chronic kidney disease.

  2008cites this paper
• Scleroderma-like fibrosing disorders.

  2008cites this paper
• Clinical and histological findings in nephrogenic systemic fibrosis.

  2008cites this paper
• Efficacy of UVA1 phototherapy in 230 patients with various skin diseases

  2008cites this paper
• Nephrogenic systemic fibrosis: an emerging entity

  2008cites this paper
• NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Treatment of Nephrogenic Systemic Fibrosis: Limited Options but Hope for the Future

  2008cites this paper
• Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis.

  2008cites this paper
• Nephrogenic systemic fibrosis and the use of gadolinium-based contrast agents

  2008cites this paper
• NSF: WHAT WE KNOW AND WHAT WE NEED TO KNOW: Nephrogenic Systemic Fibrosis: Early Recognition and Treatment

  2008cites this paper
• Nephrogenic systemic fibrosis: a review and exploration of the role of gadolinium.

  2007cites this paper
• Nephrogenic fibrosing dermopathy with recurrence after allograft failure.

  2007cites this paper
• [Nephrogenic systemic fibrosis: more hard times for renal failure patients].

  2007cites this paper
• Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.

  2007cites this paper
• Nephrogenic systemic fibrosis and gadolinium-based contrast agents

  2007cites this paper
• Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: a case series of nine patients and review of the literature

  2007cites this paper
• La fibrose systémique néphrogénique : nouveau coup dur pour les insuffisants rénaux

  2007cites this paper
• Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective StudyofaRenalReplacement

  2007cites this paper
• Nephrogenic fibrosing dermopathy: report of two cases.

  2007cites this paper
• Nephrogenic systemic fibrosis following exposure to gadolinium-containing contrast agent.

  2007cites this paper
• Gadolinium and nephrogenic systemic fibrosis: time to tighten practice

  2007cites this paper
• What nephrologists need to know about gadolinium

  2007cites this paper
• Nephrogenic systemic fibrosis--the beginning of the end?

  2007cites this paper
• Nephrogenic Systemic Fibrosis with Multiorgan Involvement in a Teenage Male after Lymphoma, Ewing's Sarcoma, End-Stage Renal Disease, and Hemodialysis

  2007cites this paper
• Nephrogenic fibrosing dermopathy: lessons from the past

  2006cites this paper
• Multiorgan involvement in nephrogenic fibrosing dermopathy: an autopsy case and review of the literature.

  2006cites this paper
• New clinical syndromes in dermatology.

  2006cites this paper
• Nephrogenic Fibrosing Dermopathy

  2006cites this paper
• The case for ultraviolet light therapy in nephrogenic fibrosing dermopathy--report of two cases and review of the literature.

  2006cites this paper
• New applications of UVA-1 cold light therapy

  2006cites this paper
• UVA1 phototherapy for cutaneous diseases: an experience of 92 cases in the United States

  2006cites this paper
• Nephrogenic fibrosing dermopathy in children

  2006cites this paper
• Nephrogenic systemic fibrosis (nephrogenic fibrosing dermopathy)

  2006cites this paper
• Update in dermatopathology.

  2006cites this paper
• 15 The Use Of Narrow-band UVB In The Treatment Of Uraemic Pruritus: A Preliminary Report

  2006cites this paper
• Ultraviolet A 1 phototherapy : One center ’ s experience

  year unknowncites this paper